NCT07308106 2026-05-11A Phase II Clinical Study of SKB571 as Monotherapy in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer With MET AbnormalitiesSichuan Kelun-Biotech Biopharmaceutical Co., Ltd.Phase 2 Recruiting60 enrolled